Phosphatidylinositol-5 phosphate (PI5P) and other mono-phosphoinositides (mono-PIs) play second messenger roles in both physiological and pathological conditions. Despite this, their intracellular targets and mechanisms of action remain poorly characterized. Here, we show that Vav1, a protein that exhibits both Rac1 GDP/GTP exchange and adaptor activities, is positively modulated by PI5P and, possibly, other mono-PIs. Unlike other phospholipid-protein complexes, the affinity and specificity of the Vav1-lipid interaction entail a new structural solution that involves the synergistic action of the Vav1 C1 domain and an adjacent polybasic tail. This new regulatory layer, which is not conserved in the Vav family paralogs, favors the engagement of optimal Vav1 signaling outputs in lymphocytes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952945 | PMC |
| http://dx.doi.org/10.3390/cells8121649 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses.
Sci Rep
August 2024
RNASA-IMEDIR, Computer Science Faculty, University of A Coruna, A Coruña, Spain.
The druggable proteome refers to proteins that can bind to small molecules with appropriate chemical affinity, inducing a favorable clinical response. Predicting druggable proteins through screening and in silico modeling is imperative for drug design. To contribute to this field, we developed an accurate predictive classifier for druggable cancer-driving proteins using amino acid composition descriptors of protein sequences and 13 machine learning linear and non-linear classifiers.
View Article and Find Full Text PDF[A highly sensitive approach for the analysis of tyrosine phosphoproteome in primary T cells].
Se Pu
July 2024
Department of Chemistry, College of Science, Southern University of Science and Technology, Shenzhen 518055, China.
Article Synopsis
- Tyrosine phosphorylation is a crucial protein modification involved in various biological processes, including T cell signaling, but its identification is challenging due to the low abundance of these phosphorylated proteins.
- The research developed a sensitive method to study tyrosine phosphorylation in primary T cells, which are typically hard to obtain and culture, by optimizing protocols for their isolation and activation from mouse spleen.
- Using specific enrichment techniques and advanced mass spectrometry, 282 tyrosine phosphorylation sites were identified in just 1 mg of protein, highlighting significant findings that differ from those in immortalized cell lines.
Full T-cell activation and function in teleosts require collaboration of first and co-stimulatory signals.
Zool Res
January 2024
State Key Laboratory of Estuarine and Coastal Research, School of Life Sciences, East China Normal University, Shanghai 200241, China. E-mail:
Mammalian T-cell responses require synergism between the first signal and co-stimulatory signal. However, whether and how dual signaling regulates the T-cell response in early vertebrates remains unknown. In the present study, we discovered that the Nile tilapia ( ) encodes key components of the LAT signalosome, namely, LAT, ITK, GRB2, VAV1, SLP-76, GADS, and PLC-γ1.
View Article and Find Full Text PDFThe , and Genes Associated with Atherosclerosis May Be Potential Diagnostic Biomarkers for Psoriasis.
J Inflamm Res
February 2023
Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangzhou, People's Republic of China.
Purpose: Psoriasis and atherosclerosis are immunometabolic diseases. This study aimed to integrate bioinformatics and updated public resources to find potential biological markers associated with atherosclerosis that can cause psoriasis.
Patients And Methods: Microarray datasets were downloaded from the Gene Expression Omnibus (GEO) database.
Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer.
J Control Release
March 2023
Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel; The Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel. Electronic address:
Pancreatic ductal adenocarcinoma (PDAC) is among the leading causes of cancer-related death, and it is highly resistant to therapy owing to its unique extracellular matrix. VAV1 protein, overexpressed in several cancer diseases including pancreatic cancer (PC), increases tumor proliferation and enhances metastases formation, which are associated with decreased survival. We hypothesized that an additive anti-tumor effect could be obtained by co-encapsulating in PLGA nanoparticles (NPs), the negatively charged siRNA against VAV1 (siVAV1) with the positively charged anti-tumor LL37 peptide, as a counter-ion.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!